U.S. market Closed. Opens in 47 minutes

AMPE | Ampio Pharmaceuticals, Inc. Stock Financials Income Statements Annual

(Stock Exchange: AMEX)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-31
RevenueN/AN/AN/AN/AN/AN/AN/AN/A1.16M76.79K50.00K50.00K18.75KN/AN/AN/AN/AN/A
Cost of Revenue250.00K2.08M1.09M1.18M1.27M523.00K568.00K950.00K369.31K2.24MN/AN/AN/AN/AN/AN/AN/AN/A
Gross Profit-250.00K-2.08M-1.09M-1.18M-1.27M-523.00K-568.00K-950.00K793.15K-2.16MN/AN/A18.75KN/AN/AN/AN/AN/A
Operating Expenses8.98M20.38M20.57M15.83M18.58M11.18M15.56M17.08M34.10M39.15M24.07M11.87M11.15M6.70M21.87K29.23K29.00KN/A
Selling, General & Admin7.08M11.47M8.67M6.65M5.90M4.36M5.14M6.54M15.13M12.22M5.79M4.38M4.50M4.73M21.87K28.28K27.80KN/A
Research & Development2.44M8.92M11.90M9.17M12.62M6.83M10.42M10.55M18.96M26.92M18.29M7.49M6.65M1.97MN/AN/AN/AN/A
Other Operating Expenses56.00K1.94MN/A12.00K56.00KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A950.001.20KN/A
Operating Income-9.52M-24.21M-25.16M-15.22M-23.45M-11.18M-15.56MN/A-33.30M-39.07M-24.02M-11.82M-11.13M-6.70M-21.87K-29.23K-29.00K-1.00K
Other Expenses / Income886.00K7.87M8.08M-676.00K9.81M45.18M-36.33M-2.08M-411.80K22.26K-504.55K227.71K-7.14M-1.35M-4.18K-2.65K-2.19KN/A
Before Tax Income-8.63M-16.34M-17.07M-15.89M-13.63M33.99M-51.89M-19.16M-33.71M-39.05M-24.53M-11.59M-18.28M-8.05M-26.05K-31.88KN/AN/A
Income Tax ExpensesN/A-7.87M-4.59M604.00K-4.95M45.17MN/AN/AN/AN/AN/AN/A82.50KN/AN/AN/AN/AN/A
Net Income-8.63M-8.47M-12.48M-16.50M-8.68M33.99M-51.89M-19.16M-32.01M-38.13M-24.01M-11.59M-18.36M-8.05M-26.05K-31.88K-32.00K-1.00K
Interest ExpensesN/A-7.87MN/AN/A77.00K-5.01KN/AN/AN/AN/AN/AN/A8.36K19.55K4.18K2.65KN/AN/A
Basic Shares Outstanding809.00K753.62K664.33K576.15K474.03K384.49K4.35M53.77M51.99M50.23M38.29M33.98M26.01M16.29M929.72K929.72K929.71K929.71K
Diluted Shares Outstanding810.11K753.62K671.49K595.41K474.03K384.49K4.35M53.77M51.99M50.23M38.29M33.98M26.01M16.29M929.72K929.72K929.71K929.71K
EBITDA-9.39M-23.16M-24.06M-14.04M-22.17M-55.08M-50.68M-15.87M-30.87M-37.69M-23.87M-11.53M-18.23M-6.70M-21.87K-29.23K-26.81K-1.00K
EBITDA Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%-2,655.91%-49,079.03%-47,741.76%-23,061.30%-97,204.40%0.00%0.00%0.00%0.00%0.00%
EBIT-8.63M-24.21M-17.07M-15.89M-13.55M79.15M-51.89M-19.16M-32.01M-38.13M-24.01M-11.59M-18.27M-8.03M-21.87K-29.23K-32.00K-1.00K
EBIT Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%-2,753.66%-49,650.87%-48,017.12%-23,186.09%-97,431.34%0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙